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● Background.—Dysgenetic male pseudohermaphroditism
(DMP) is a sexual differentiation disorder characterized by
bilateral dysgenetic testes, persistent mu¨llerian structures,
and cryptorchidism in individuals with a 46,XY karyotype.
However, the histologic criteria for the diagnosis of DMP
are poorly established.
Objective.—To determine gonadal histology in children
with DMP.
Patients and Methods.—Between 1996 and 1998, 13 pa-
tients with DMP were evaluated on our service. The clin-
ical diagnosis of DMP was based on a 46,XY karyotype, sex
ambiguity, high levels of follicle-stimulating hormone and
low levels of antimu¨llerian hormone, a decreased testos-
terone response to human chorionic gonadotropin stimu-
lation without accumulation of testosterone precursors,
and the presence of mu¨llerian structures. Molecular se-
quencing the HMGbox region of the SRY gene did not re-
veal any mutations. Biopsies were performed for 22 of 26
gonads (patient age at the time of biopsy, 16 months to 10
years). Conventional microscopy was used to evaluate
mean tubular diameter, tubular fertility index, and number
of Sertoli cells per tubular profile.
Results.—All 26 gonads were located outside of the la-
bioscrotal folds. Their histologic features varied from only
a reduction in tubular size to features of a streak gonad.
Five of the 22 gonads grossly resembled a streak gonad.
The mean tubular diameter was severely reduced (.30%
reduction relative to the normal tubular diameter for the
patient’s age) in 4 gonads, markedly reduced (10%–30%)
in 11 gonads, slightly reduced (,10%) in one gonad, and
normal in one gonad. The tubular fertililty index, expressed
as the percentage of tubular profiles containing germ cells,
was severely reduced (,30% of normal values) in 9 go-
nads, markedly reduced (50%–30%) in 2 gonads, and nor-
mal in 6 gonads. The number of Sertoli cells per tubular
profile was elevated in 16 gonads and normal in one go-
nad. Thin tubules surrounded by fibrous tissue were oc-
casionally observed.
Conclusion.—The histologic findings confirmed the clin-
ical diagnosis of DMP in every patient in the present series.
However, gonadal histology was variable, and careful mor-
phometric evaluation may be necessary to establish the di-
agnosis.
(Arch Pathol Lab Med. 2001;125:652–656)
Dysgenetic male pseudohermaphroditism (DMP) is asexual differentiation disorder diagnosed on the
basis of morphologic features in patients with evidence
of gonadal dysgenesis. Typically, patients have ambig-
uous genitalia, low testosterone levels, persistence of
mu¨llerian structures, bilateral abnormal testes, and an
increased risk for gonadal neoplastic transformation.1–4
Depending on the severity of testicular dysgenesis, the
antimu¨llerian hormone (AMH) level may be low or un-
detectable in patients with abnormal testicular deter-
mination.5,6 Typically, the gonadal histology is charac-
terized by poorly developed seminiferous tubules sur-
rounded by wavy ovarian stroma. However, gonadal de-
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velopment may range from apparently normal
testicular differentiation to a streak gonad, and the cri-
teria for the histologic diagnosis of DMP are not well
established.
The most frequently observed karyotype in patients
with DMP is 46,XY. However, multiple cell lines, including
a monosomic X cell line, may be detected, and somatic
features of Turner syndrome, such as short stature,
webbed neck, cubitus valgus, and renal malformation, may
be present.7
In fact, some authors consider DMP a variant of mixed
gonadal dysgenesis,4,8–9 which is defined as the coexistence
of a streak gonad and a dysgenetic testis in a patient with
a 45,X/46,XY karyotype.1,8,10 In order to rule out the pres-
ence of Denys-Drash syndrome, which occurs as a con-
sequence of mutations at the WT1 gene on chromosome
11, patients with DMP must be examined periodically for
the presence of Wilms tumor and nephropathy with pro-
gressive renal failure.11
The objective of this study was to better define the his-
tologic criteria for the diagnosis of DMP by determining
the morphometric and histologic features of the gonads
of 13 children with a strict clinical diagnosis of this en-
tity.
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Table 1. Clinical and Hormonal Data of 13 Children With Dysgenetic Male Pseudohermaphroditism*
Patient Age, mo
External
Genitalia†
Position
of the
Gonads,
R/L
AMH,
pmol/L
T,
nmol/L‡
b-hCG,
IU/L
LH,
IU/L§
FSH,
IU/L\
1
2
3
4
5
6
7
8
9
10
11
12
13
7
108
30
0.5
10
92
78
13
20
20
31
29
44
3
2
2
3
2
2
2
2
4
2
3
3
3
I/I
A/A
I/I
I/I
I/I
I/A
I/2
I/I
I/A
A/A
I/I
A/A
I/A
118
114
52
98
114
113
73
107
11
91
25
116
71
1.4
0.7
,0.3
1.7¶
,0.3
1.0
,0.3
,0.3
,0.3
,0.3
,0.3
3.1
,0.3
NP
NP
319
NP
351
NP
301
196
351
219
143
NP
365
1.0
0.9
0.6
0.8
1.1
0.8
1.0
0.5
1.1
1.0
0.1
0.3
0.9
1.3
5.4
1.2
3.9
1.4
5.8
6.3
1.0
1.5
1.4
0.8
0.7
0.9
* R indicates right; L, left; AMH, antimu¨llerian hormone; T, testosterone; b-hCG, b-human chorionic gonadotropin; LH, luteinizing hormone;
FSH, follicle-stimulating hormone; A, abdomen; I, inguinal canal; 2, not found; and NP, not performed.
† According to the classification of Quigley et al.21
‡ Total testosterone level after hCG stimulation test.
§ Normal values of prepubertal LH: 0.1–1.0 IU/L.
\ Normal values of prepubertal FSH: 0.1–1.4 IU/L.
¶ Basal total testosterone level.
SUBJECTS AND METHODS
Subjects
The series consisted of 13 patients with a clinical diagnosis of
DMP evaluated by the Interdisciplinary Group for the Study of
Sex Determination and Differentiation at the University Hospital
of the UNICAMP (Campinas, Sa˜o Paulo, Brazil), between May,
1996, and May, 1998. The diagnosis of DMP was supported by
the findings of ambiguous genitalia in patients with a 46,XY kar-
yotype and bilateral cryptorchidism, low levels of testosterone
and AMH, and evidence of mu¨llerian duct derivatives. This study
was approved by the Ethics Committee of the University Hos-
pital.
The patients’ mean age at first consultation was 3 years and 1
month (range, 15 days to 9 years), and the initial sex assignment
was male in all cases. One patient (case 12) had a previous history
of unilateral Wilms tumor and renal failure. No consanguinity
was registered, and there was no family history of sex ambiguity.
All individuals had hypospadias, bilateral cryptorchidism (Table
1), and evidence of mu¨llerian duct derivatives, which was con-
firmed by laparoscopy.
Routine hormonal determination was performed by radioim-
munoassay and included basal levels of luteinizing hormone
(LH), follicle-stimulating hormone (FSH), androstenedione, and
dehydroepiandrosterone. Total testosterone levels were deter-
mined before and 24 hours after the last of a series of 3 daily
intramuscular injections of 2000 IU of human chorionic gonado-
tropin (hCG) (Profasi hp, Serono Lab, Sa˜o Paulo, Brazil). An in-
crease in testosterone level of more than 4.9 nmol/L (1.4 ng/mL)
was considered normal. When testosterone levels did not in-
crease, determination of serum b-hCG was performed to confirm
that it was really used. Serum AMH levels were measured by an
enzyme-linked immunosorbent assay, using antibodies against
human recombinant AMH,12 in the laboratory of the Unite´ de
Recherches sur l’Endocrinologie du De´veloppement (INSERM),
Montrouge, France. In one patient (patient 4), who was less than
6 months of age, testosterone levels were assayed only in baseline
blood samples, because, at this age, testosterone values in normal
children are elevated. All patients had low AMH levels as com-
pared with the normal values published by Rey et al.5 They also
had decreased testosterone levels either at baseline or after hCG
stimulation, with no accumulation of testosterone precursors. All
patients had a predominance of FSH over LH, despite the fact
that only 5 patients (patients 2, 4, 6, 7, and 8) had elevated go-
nadotropin levels (Table 1).
Genomic DNA samples from each patient and normal male
and female controls were previously used as templates to amplify
the HMGbox region of the SRY gene and no mutations were
found after direct sequencing of polymerase chain reaction prod-
ucts.
Methods
The biopsies of gonads were fixed in Bouin solution, dehy-
drated in alcohol, and embedded in paraffin. Serial 4-mm sections
from each part of the gonads were stained with hematoxylin-
eosin and examined under light microscopy. The mean tubular
diameter, tubular fertility index (TFI), and Sertoli cell number per
tubular profile were evaluated in 50 to 100 randomly selected
seminiferous tubules of each section. Our findings were com-
pared with the normal data for age published by Nistal and Pan-
iagua (Figure 1).13
The mean tubular diameter of both the longitudinal and trans-
verse sections was measured using a calibrated vernier ocular
micrometer with a 403 objective, as described by Lennox et al.14
The reduction of diameter was classified according to Nistal and
Paniagua13 into 3 degrees of severity: slight (,10% reduction in
relation to the normal diameter for the age), marked (10%–30%
reduction), and severe (.30% reduction) tubular hypoplasia.
Germ cell number was evaluated by determining the TFI,
which is the mean number of germ cells per tubular profile. This
value was calculated by counting the number of germ cells in a
single light microscope field and dividing that number by the
number of tubular profiles in that given field. According to Nistal
and Paniagua,13 3 levels of severity of germinal hypoplasia can
be recognized: slight (TFI, .50%), marked (TFI, of 50%–30%) and
severe (TFI, ,30%).
The number of Sertoli cells per tubular profile was determined.
The Leydig cell number was not evaluated because this number
is low during infancy. Streak gonads were defined as those com-
posed of an ovarian-type stroma with sclerohyaline nodules.
RESULTS
Biopsies were performed for 22 of the 26 gonads. The
patients’ ages at the time of biopsy ranged from 16 months
to 10 years (Table 2). Biopsies were not performed for 4
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Figure 1. Changes in the mean tubular diameter (MTD), tubular fer-
tility index (TFI), and Sertoli cell number (SCN) profiles from birth to
puberty (adapted from Nistal and Paniagua13).
Figure 2. Tissue from patient 4. An area of left gonad (hematoxylin-
eosin, original magnification 375).
Figure 3. Tissue from patient 12. An area of right gonad showing
marked tubular hypoplasia, severe germinal hypoplasia, and hyperpla-
sia of Sertoli cells (hematoxylin-eosin, original magnification 3150).
Figure 4. Tissue from the right gonad of patient 12 (hematoxylin-eo-
sin, original magnification 3300).
gonads: the left gonad of patients 1 and 7, and the right
gonad of patients 2 and 4. The left gonad of patient 7 was
not found, but the ipsilateral absence of mu¨llerian duct
derivatives and the presence of wolffian duct derivatives
suggested a unilateral vanishing testis. In the other 3 pa-
tients, the biopsy of one of the gonads was not suitable
for histologic analysis.
There were 5 streak gonads (the left gonad of patients
2, 6, 9, 10, and 13), which were all in an abdominal po-
sition.
Table 2 shows values for the mean tubular diameter,
TFI, and number of Sertoli cells per tubular profile ob-
served in the 17 remaining gonads.
Eleven gonads showed marked tubular hypoplasia, 4
showed severe tubular hypoplasia, and one showed slight
tubular hypoplasia (Figures 2 through 4). The mean tu-
bular diameter was normal in only one gonad (the right
gonad of patient 13).
The TFI was severely reduced in 9 gonads, markedly
reduced in 2 gonads (Figures 2 through 4), and normal in
6 gonads.
The Sertoli cell number per tubular profile was elevated
in 16 of 17 gonads analyzed (Figures 2 through 4). Only
the right gonad of patient 13 showed a normal number of
Sertoli cells.
COMMENT
Ambiguous development of the genital ducts, urogeni-
tal sinus, and external genitalia occurs in patients with
dysgenetic gonads. These patients usually present with
evidence of AMH deficiency as well as androgen deficien-
cy, and therefore have mu¨llerian duct derivatives and am-
biguous external genitalia.8 Mutations and deletions in
genes involved in the testes determination and differen-
tiation cascade have been implicated in the etiology of
DMP.15
Our 13 patients presented with some interesting find-
ings: all had a male sex assignment before the first con-
sultation, and there was a delay in the evaluation of the
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Table 2. Morphometric and Histologic Data of 22 Gonads From 13 Children With Dysgenetic Male
Pseudohermaphroditism*
Patient
Age,
mo†
No. Tubular
Profiles
Examined
MTD,
mm STH TFI, % SGH SCN HSC
1
2
3
4
5
6
7
8
9
10
11
12
13
11
122
36
16
16
108
84
19
26
27
36
37
51
R, 110
L, 2
R, 69
L, 104
L, 117
R, 102
L, 101
R, 99
L, 2
R, 104
R, 126
L, 116
R, 42
L, 2
R, 98
L, 2
R, 104
L, 115
R, 98
L, 80
R, 66
L, 2
52.3
. . .
29.1
35.8
49.6
46.8
49.1
59.5
. . .
39.4
54
52.4
38.3
. . .
43.9
. . .
49.6
53.1
49.2
43.4
64.1
. . .
Marked
Streak
Severe
Severe
Marked
Marked
Marked
Slight
Streak
Severe
Marked
Marked
Severe
Streak
Marked
Streak
Marked
Marked
Marked
Marked
Normal
Streak
12
. . .
0
15
10
78
97
6
. . .
111
68
166
50
. . .
0
. . .
33
45
0
10
115
. . .
Severe
Streak
Severe
Severe
Severe
Normal
Normal
Severe
Streak
Normal
Normal
Normal
Severe
Streak
Severe
Streak
Marked
Marked
Severe
Severe
Normal
Streak
28
. . .
19
22
29
23
24
29
. . .
21
19
19
26
. . .
18
. . .
30
33
37
32
24
. . .
1
Streak
1
1
1
1
1
1
Streak
1
1
1
1
Streak
Normal
Streak
1
1
1
1
1
Streak
* MTD indicates mean tubular diameter; STH, severity of tubular hypoplasia according to Nistal and Paniagua13; TFI, tubular fertility index; SGH,
severity of germinal hypoplasia according to Nistal and Paniagua13; SCN, Sertoli cell number per tubular profile; HSC, hyperplasia of Sertoli cells
according to Nistal and Paniagua13; R, right gonad; L, left gonad; 2, absence of seminiferous tubules; and 1, present.
† Age at which gonadal biopsy was performed.
ambiguous genitalia (mean age at the time of evaluation,
3 years and 1 month). Although all patients had a pre-
dominance of FSH over LH, only 5 of them had high FSH
levels for their age. Among these 5 patients, 3 were older
than 6 years, 1 was 15 days old, and 1 was 1 year old,
suggesting that gonadotropins may be useful in the di-
agnosis of DMP at the extremes of prepubertal age. Vari-
able degrees of masculinization of the external genitalia
were noted, and the gonads were located outside of the
labioscrotal folds in all patients. One patient (patient 12)
had features of Denys-Drash syndrome.
The diagnostic confirmation of DMP is based on the
histologic finding of variable degrees of bilateral dysge-
netic testes, which range from an almost ‘‘normal’’ testis
to a testis that grossly resembles a streak gonad. Although
the abnormalities observed in dysgenetic testes are well
defined, pathologists usually have some difficulties estab-
lishing the diagnosis of dysgenetic testes, and the char-
acteristics of dysgenetic gonads are not routinely evaluat-
ed.
Testicular biopsy is essential for the diagnosis in some
patients with ambiguous genitalia, and the evaluation of
biopsies of prepubertal testes should involve assessment
of the mean tubular diameter and the number of germ
cells, Sertoli cells, and Leydig cells (when evaluated) per
tubular profile, per unit area, per unit volume, or per tes-
tis.
Mean tubular diameter is a very good indicator of the
development of the seminiferous epithelium.13 In the pre-
pubertal testis, this diameter depends mainly on the num-
ber of Sertoli cells, and thus indicates whether they are
adequately stimulated by FSH and responsive to this stim-
ulus. Testicular diameter varies throughout childhood; it
is smallest in the fourth year of life, increases slowly until
9 years of age, and increases rapidly thereafter, up to 15
years of age (Figure 1).13 Our patients with DMP showed
a variable mean tubular diameter, from normal to severely
decreased, but with a predominance of marked and severe
tubular hypoplasia (15/17 gonads). Even though there are
technical pitfalls in evaluating the mean tubular diameter,
our data indicate the need for this evaluation in all testic-
ular biopsies when there is clinical suspicion of gonadal
dysgenesis, independent of the gonadal location.
Germ cells may be counted by several methods. The
most common method is calculating the TFI, which re-
flects the percentage of tubular profiles containing germ
cells. In neonates, 68% of tubular profiles contain at least
one germ cell. From birth to 3 years, this value decreases
to 50%, followed by a progressive increase to 100% at pu-
berty (Figure 1).13 A more complete determination of germ
cell number can be obtained by calculating the total num-
ber of germ cell per testis, but this approach requires mor-
phometric assessment of the intratubular volume and
careful clinical measurement of the 3 axes of the testis.16
The TFI was altered in 11 of the 17 testes that we evalu-
ated. Among the 6 patients with dysgenetic testes and nor-
mal TFIs, 5 had a decreased and 1 had a normal mean
tubular diameter. Therefore, our data suggest that mean
tubular diameter is a better indicator of testicular dysgen-
esis than TFI.
Another histologic parameter evaluated was the number
of Sertoli cells per tubular profile, which varies during
childhood as a result of low levels of Sertoli cell prolifer-
ation between the ages of 4 and 12 years.17 Hyperplasia of
Sertoli cells is usually pronounced in patients with DMP,
and it is a sign of tubular dysgenesis.18 The number of
Sertoli cells was increased in all of the gonads of our pa-
tients with DMP, but in one patient, this increase was not
marked (Figure 1). This finding probably reflects the fact
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that the ideal time for this evaluation is during the first
year of life or at the onset of puberty.
Finally, it is important to emphasize that among the 22
evaluated gonads, only 5 grossly resembled streak gonads.
It is interesting to point out that they were all found on
the left side; among true hermaphrodites, there is also a
predominance of ovaries and ovotestes on the left side.19,20
In conclusion, the histologic findings in our patients
with DMP, although highly variable, confirmed the clinical
diagnosis. A careful histologic and morphometric evalu-
ation, particularly the measurement of mean tubular di-
ameter, may help establish and improve the diagnosis of
DMP.
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